| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.0322 | 56 |
| GSM780708 | Untreated after 4 days (C2_1) | 53.3225 | 57 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.5378 | 55 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.7081 | 53 |
| GSM780720 | Untreated after 4 days (C2_2) | 58.8439 | 64 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.6431 | 30 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 77.0401 | 71 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 63.7077 | 67 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 86.2511 | 73 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 72.3627 | 70 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 64.0006 | 67 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 99.2746 | 75 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 49.5667 | 47 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 62.0406 | 66 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 61.4769 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.9334 | 36 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 69.0995 | 69 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 62.8386 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 66.6019 | 68 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 79.1706 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 88.6129 | 73 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 72.2023 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 84.0363 | 73 |